{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:12:58Z","timestamp":1789999978927,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010002","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["103-2325-B-400-012"],"award-info":[{"award-number":["103-2325-B-400-012"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["CA-103-PP-22"],"award-info":[{"award-number":["CA-103-PP-22"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004866","name":"National Research Program for Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007750","name":"National Cheng Kung University","doi-asserted-by":"publisher","award":["D103-35A09"],"award-info":[{"award-number":["D103-35A09"]}],"id":[{"id":"10.13039\/501100007750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["CA103-SP-01"],"award-info":[{"award-number":["CA103-SP-01"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.bcp.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T21:09:17Z","timestamp":1428268157000},"page":"28-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Mechanistic basis of a combination d-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo"],"prefix":"10.1016","volume":"95","author":[{"given":"Szu-Jung","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chuan","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsui-Chun","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szu-Ching","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang-Yang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2015.03.006_bib0180","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/annonc\/mdh422","article-title":"Palliative chemotherapy for advanced gastric cancer","volume":"15","author":"Wohrer","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0185","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.3748\/wjg.v17.i39.4421","article-title":"Comparative epidemiology of gastric cancer between Japan and China","volume":"17","author":"Lin","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0190","first-page":"451","article-title":"Dynamic alteration of gene expression induced by anticancer-agent exposure in gastric cancer cell lines","volume":"21","author":"Takahashi","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2015.03.006_bib0195","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.pharmtox.48.080907.180426","article-title":"The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy","volume":"48","author":"Hall","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"Suppl. 4","key":"10.1016\/j.bcp.2015.03.006_bib0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200059004-00001","article-title":"Preclinical perspectives on platinum resistance","volume":"59","author":"Kelland","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.bcp.2015.03.006_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4061\/2010\/201367","article-title":"Cellular responses to Cisplatin-induced DNA damage","volume":"2010","author":"Basu","year":"2010","journal-title":"J. Nucleic Acids"},{"key":"10.1016\/j.bcp.2015.03.006_bib0210","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/mol.109.063172","article-title":"Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs","volume":"77","author":"Howell","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0215","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10555-007-9045-3","article-title":"The roles of copper transporters in cisplatin resistance","volume":"26","author":"Kuo","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bcp.2015.03.006_bib0220","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1158\/0008-5472.CAN-12-0888","article-title":"Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy","volume":"72","author":"Kuo","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2015.03.006_bib0225","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1158\/1535-7163.MCT-12-0580","article-title":"Mechanistic basis for overcoming platinum resistance using copper chelating agents","volume":"11","author":"Liang","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2015.03.006_bib0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1124\/mol.108.046771","article-title":"Transcription factor Sp1 plays an important role in the regulation of copper homeostasis in mammalian cells","volume":"74","author":"Song","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0235","doi-asserted-by":"crossref","first-page":"9221","DOI":"10.1074\/jbc.272.14.9221","article-title":"Identification and functional expression of HAH1, a novel human gene involved in copper homeostasis","volume":"272","author":"Klomp","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2015.03.006_bib0240","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1124\/mol.64.2.466","article-title":"The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells","volume":"64","author":"Katano","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0245","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.critrevonc.2004.09.007","article-title":"Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs","volume":"53","author":"Safaei","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/mol.66.1.25","article-title":"Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B","volume":"66","author":"Samimi","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0255","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/sj.bjc.6603866","article-title":"Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil","volume":"97","author":"Chen","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2015.03.006_bib0260","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.bcp.2013.07.025","article-title":"Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2\/AKR1 C axis identification","volume":"86","author":"Chen","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0265","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2015.03.006_bib0270","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2015.03.006_bib0275","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1158\/0008-5472.CAN-09-4161","article-title":"Dysregulation of p53\/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer","volume":"70","author":"Lin","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2015.03.006_bib0280","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/mol.54.5.770","article-title":"Sequence- and region-specificity of oxaliplatin adducts in naked and cellular DNA","volume":"54","author":"Woynarowski","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0285","first-page":"227","article-title":"Cellular and molecular pharmacology of oxaliplatin","volume":"1","author":"Raymond","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2015.03.006_bib0290","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0006-2952(97)81490-6","article-title":"Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel","volume":"52","author":"Rixe","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0295","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2005.07.046","article-title":"Role of copper transporters in the uptake and efflux of platinum containing drugs","volume":"234","author":"Safaei","year":"2006","journal-title":"Cancer Lett."},{"issue":"Suppl. 4","key":"10.1016\/j.bcp.2015.03.006_bib0300","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/bjc.1998.429","article-title":"Ongoing and unsaid on oxaliplatin: the hope","volume":"77","author":"Cvitkovic","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2015.03.006_bib0305","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1040-8428(00)00070-6","article-title":"Oxaliplatin clinical activity: a review","volume":"35","author":"Misset","year":"2000","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0310","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/bjc.1989.356","article-title":"Cisplatin\/carboplatin cross-resistance in ovarian cancer","volume":"60","author":"Gore","year":"1989","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2015.03.006_bib0315","first-page":"86","article-title":"Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts","volume":"45","author":"Boven","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2015.03.006_bib0320","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4161\/cbt.5.8.2876","article-title":"Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter","volume":"5","author":"Helleman","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bcp.2015.03.006_bib0325","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1124\/mol.106.022624","article-title":"Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin","volume":"70","author":"Holzer","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0330","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1158\/0008-5472.CAN-13-3527","article-title":"Copper signaling axis as a target for prostate cancer therapeutics","volume":"74","author":"Safi","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2015.03.006_bib0335","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/hep.22261","article-title":"Diagnosis and treatment of Wilson disease: an update","volume":"47","author":"Roberts","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2015.03.006_bib0340","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/1535-7163.MCT-11-0864","article-title":"Overcoming platinum resistance through the use of a copper-lowering agent","volume":"11","author":"Fu","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bcp.2015.03.006_bib0345","article-title":"Using synthetic lethal screening to identify therapeutic targets for innately platinum resistant lung cancer","volume":"8","author":"Marini","year":"2013","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.bcp.2015.03.006_bib0350","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.2174\/0929867321666140414102701","article-title":"Targeting platinum resistant disease in ovarian cancer","volume":"21","author":"Morgan","year":"2014","journal-title":"Curr. Med. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215001513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295215001513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:59:24Z","timestamp":1757768364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295215001513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0006295215001513"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2015.03.006","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic basis of a combination d-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}